VISION WITH RESTOR® , ARRAY® SA40 AND A MONOFOCAL INTRA-OCULAR LENS (IOL) AFTER CATARACT SURGERY

Author(s)

Gilles Berdeaux, MD, Associate Director1, Niels De vries, MD, Docteur2, Antoine Lafuma, MD, Director3, Caroline Laurendeau, MSc, Project manager4, Rudy Nuijts, MD, PhD, Professor21Alcon France, Rueil-Malmaison, France; 2 University Hospital Maastricht, Maastricht, Netherlands; 3 Cemka eval, Bourg-la-Reine, France; 4 Cemka-Eval, Bourg-la-Reine, France

OBJECTIVES: The aim of this study was to compare vision 6 months after cataract surgery in patients implanted with one of three IOLs: a monofocal or a multifocal (ReSTOR® or ARRAY-SA40®).  The latter two often free patients from spectacles for near and distance vision. METHODS: A randomized clinical trial comparing ARRAY-SA40® with a monofocal was pooled with a prospective cohort of patients implanted with ReSTOR®. Patient satisfaction, spectacle freedom rate, and corrected and uncorrected, near and distance visual acuities (VA) were measured six months after surgery. Treatment group comparability was checked at baseline. Imbalances on confounding factors were adjusted using both linear models and propensity scores. RESULTS: Sixtry-nine patients had a monofocal, 68 received the ARRAY-SA40® and 83 were implanted with ReSTOR®. ReSTOR® patients were younger (P<0.0001) and had a lower neuroticism score (P<0.001). The sex-ratio was six females: four males. VA and spectacle dependency at baseline were comparable. At 6 months no difference was observed on distance VA, corrected or uncorrected. Uncorrected near VA of ReSTOR® patients was better (P<0.0001) than with either a monofocal IOL or ARRAY-SA40®. The probability of being free of spectacles with ReSTOR was higher (P<0.0001) than with a monofocal (RR=10.2) or an ARRAY-SA40® (RR=10.7). ReSTOR® patients wearing spectacles never had multifocal glasses (the most expensive), while 32% of ARRAY-SA40® and 52% of the monofocal patients did. Good or excellent near vision satisfaction with ReSTOR® was more often reported by patients than with the ARRAY-SA40® or a monofocal (83.6%, 32.4%, 26.1%, respectively; P<0.0001).  The corresponding satisfaction difference did not reach statistical significance with distance vision (82.1%, 75.0%, 67.7%, respectively; P<0.17). Linear and propensity score adjustments did not modify the results. CONCLUSIONS: The uncorrected distance VA of the three IOLs was similar. Near uncorrected VA in ReSTOR® patients was better than in patients implanted with a monofocal or ARRAY-SA40®, resulting in a higher spectacle independence rate and better near vision patient satisfaction

Conference/Value in Health Info

2008-11, ISPOR Europe 2008, Athens, Greece

Value in Health, Vol. 11, No. 6 (November 2008)

Code

PSS3

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×